|
他汀类药物对慢性心力衰竭治疗作用的新认识 |
| |
bsp;fluv- astatin via the inhibition of nicotinamide adenine dinucleotide phosphate(NADPH)oxidase activity[J]. Biol Pharm Bul,l 2003, 26(6): 818-822.
[12] Maack C,KartesT,KilterH,et al. Oxygen free radical release in human failingmyocardium is associated with increased activity of rac1-GTPase and represents a target for statin treatment[J].Circu- lation, 2003, 108(13): 1567-1574.
[13] MitchellLB, Powell JL, GillisAM,et al. Are lipid lowering drugs also antiarrhythmic drugs? An analysis of the antiarrhythmics versus implantable defibrillators(AVID)trial [J]. JAm CollCar- dio,l 2003, 42(1): 81-87.
[14] HasegawaH,YamamotoR,TakanoH,et al. 3-hydroxy-3-methylgl- utaryl coenzymeA reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats [J]. JMolCellCardi- o,l 2003, 35(8): 953-960.
[15] CORONA Group.Rosuvastatin in older patientswith systolic heart failure [J].N Engl JMed, 2007, 357(5): 2248-2261.
[16] Horwich TB,HamiltonMA,MaclellanWR,et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure[J].CardiolFai,l 2002, 8(4): 216-224.
[17] RauchhausM, Clark AL, DoehnerW,et al. The relat上一页 [1] [2] [3] [4] [5] [6] 下一页
上一个医学论文： 不同治疗方法对高龄血液透析患者低血压的干预效果
下一个医学论文： 钙网蛋白抗肿瘤免疫治疗的新靶点
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文